nivolumab
Showing 1 - 25 of 806
Melanoma Trial in Rotterdam (Nivolumab)
Recruiting
- Melanoma
- Nivolumab
-
Rotterdam, Pending, NetherlandsErasmus MC
Oct 30, 2023
Melanoma Trial (ABP 206, Nivolumab)
Not yet recruiting
- Melanoma
- ABP 206
- Nivolumab
- (no location specified)
Sep 20, 2023
Acute Anterior ST Segment Elevation Myocardial Infarction Trial (Nivolumab, Placebo)
Not yet recruiting
- Acute Anterior ST Segment Elevation Myocardial Infarction
- Nivolumab
- Placebo
- (no location specified)
Jun 6, 2023
Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)
Not yet recruiting
- Renal Cell Carcinoma
- Tivozanib
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Sep 19, 2023
Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)
Not yet recruiting
- Melanoma Stage IV
- +3 more
- nivolumab
- (no location specified)
Dec 14, 2022
Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)
Not yet recruiting
- Melanoma (Skin)
- BMS-986213 (Relatlimab-Nivolumab FDC)
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Amsterdam, Noord Holland, NetherlandsNKI-AVL
Oct 24, 2022
Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Combination 5-azacytidine and nivolumab
- +2 more
- (no location specified)
Dec 7, 2022
RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)
Not yet recruiting
- RCC
- Renal Cell Carcinoma
- Cabozantinib 80 MG
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Jul 3, 2023
Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)
Recruiting
- Melanoma
- Metastatic Melanoma
- CDX-301
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 12, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,
Recruiting
- Metastatic Gastric Cancer
- +2 more
- Nivolumab
- +2 more
-
New York, New YorkBureau for Cancer Research
May 10, 2023
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial
Not yet recruiting
- Metastatic Nasopharyngeal Carcinoma
- +2 more
- Nivolumab
- +5 more
- (no location specified)
Aug 21, 2023
Metastatic Renal Cell Carcinoma Trial in Italy (Axitinib, Nivolumab)
Not yet recruiting
- Metastatic Renal Cell Carcinoma
- Axitinib
- Nivolumab
-
Brescia, Italy
- +22 more
Apr 19, 2023
Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023
Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)
Terminated
- Hepatocellular Carcinoma
- Abemaciclib
- Nivolumab
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 17, 2022
Pancreatic Cancer Trial in Herlev (drug, radiation, biological)
Not yet recruiting
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Feb 8, 2023
Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)
Recruiting
- Metastatic Melanoma
- Metastasis to Brain
- Nivolumab
- +3 more
-
Tampa, Florida
- +1 more
Jan 30, 2023
Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Merkel Cell Carcinoma
- Skin Cancer
- Nivolumab
- +2 more
-
Tampa, Florida
- +1 more
Nov 11, 2022
Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)
Not yet recruiting
- Hodgkin Lymphoma
- Axatilimab
- Nivolumab
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Feb 1, 2023
Hodgkin Lymphoma Trial in Moscow (Nivolumab)
Recruiting
- Hodgkin Lymphoma
- Nivolumab
-
Moscow, Russian FederationNational Research Center for Hematology
Dec 13, 2022
Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)
Not yet recruiting
- Endometrial Neoplasms
- Endometrial Cancer
- Nivolumab
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Mar 21, 2023
IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)
Not yet recruiting
- IDH1-mutant Cholangiocarcinoma
- Ivosidenib
- +3 more
- (no location specified)
Jun 29, 2023